Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Act-On Software Launches Innovative Affiliate Program for Streamlined Customer Referrals
-
ThermoFab welcomes Mustafa Hossaini as Senior Business Development Manager
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 05 08 2024] - (CGWL)
-
Entourage Health to Host Second Quarter 2024 Financial Results Call
-
Terms for Nykredit's and Totalkredit's auctions - Totalkredit A/S
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
-
July 2024 Monthly Investor Update
-
Hillman Reports Second Quarter 2024 Results
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
Surgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 Guidance
-
Bioventus Reports Second Quarter Financial Results
-
BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights
-
Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
AYR Wellness Launches Adult-Use Sales in Ohio
-
Brixton Metals Provides Assays from the Second Camp Creek Drill Hole of the 2024 Exploration Program with an Upper 61.5m Gold Dominant Zone and a Lower 1126.05m Interval of Porphyry Copper Dominant Zo
-
Genie Energy Announces Second Quarter 2024 Results
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14
-
Alimera Sciences Reports Second Quarter 2024 Results
-
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
-
iSpecimen Reports Second Quarter 2024 Results
-
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
-
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
AS Tallink Grupp: Managers’ Transactions
-
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
-
Hillman Announces Leadership Succession Plans: COO Jon Michael Adinolfi to be Appointed as Next CEO; CEO Doug Cahill to Become Executive Chairman
-
Novo Nordisk A/S - share repurchase programme
-
Tecan schedules conference call on August 13th to discuss half year 2024 financial results
-
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
-
MSHS / Pacific Power Group Announces New Marine Service Center on Lake Union
-
Asante Provides Update on Project Development and Operations
-
NorthWest Copper Publishes Annual ESG Report
-
Evergold Prepares to Drill Crucial Follow-up Holes at DEM Gold Discovery, B.C.
-
First Watch Restaurant Group, Inc. Reports Q2 2024 Financial Results
-
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
-
Xali Gold Trading Halt
-
The Eclipse Foundation Announces Agenda and Keynote Speakers for Open Community Experience (OCX 2024), Europe’s Premier Event for Open Source Innovation
-
BioXcel Therapeutics Reports Second Quarter 2024 Financial Results
-
NFI subsidiary New Flyer named as partner of choice for more than $338 million in FTA Low- or No-Emission and Buses and Bus Facilities grants
-
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options
-
American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico
-
Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
-
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Fuller Theological Seminary Announces the Launch of "The New Testament in Color"
-
Hemlo Explorers Enters Share Purchase Agreements for the Acquisition of Rocky Shore Metals and its Gold Anchor Project
-
NexGold Mining and Wabigoon Lake Ojibway Nation Sign New Relationship Agreement for Goliath Gold Complex
